相关实验视频

Updated: Jan 18, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

促进神经营养路径的植物化学物质:来自大脑的神经营养因素作为抑郁症中的分子标

Vaibhav Karad¹, Girdhari Lal Gupta²

¹Department of Pharmacology, School of Pharmacy & Technology Management, SVKM's NMIMS Deemed to Be University, Shirpur, Maharashtra, 425405, India.

Naunyn-Schmiedeberg's archives of pharmacology

|June 9, 2025

概括

植物化学物质通过增强脑衍生神经营养因子 (BDNF) 和神经可塑性,显示出抗抑郁的潜力. 需要进一步的研究和改进的输送方法来克服局限性,并将这些天然化合物发展为有效的抑郁症治疗方法.

科学领域:

神经科学是一个神经科学.
药理学药理学是指药理学的学科.
自然产品化学自然产品化学

背景情况:

大型抑郁症 (MDD) 涉及神经营养因子失调,特别是减少脑源性神经营养因子 (BDNF).
像SSRI这样的常规抗抑郁药具有局限性,包括延迟发作和可变的有效性.
植物化学物质正在成为潜在的治疗剂,针对抑郁症的BDNF途径.

研究的目的:

审查植物衍生生物活性化合物在调节抑郁症神经营养路径中的作用.
为了探索针对BDNF信号通路的植物化学物质的抗抑郁药类特性.
讨论改善植物化学品在抑郁症治疗中的临床应用的新兴策略.

主要方法:

对植物化学物质,BDNF,神经可塑性和抑郁症研究的文献综述.
通过植物化学物质调节的信号通路 (例如PI3K/Akt/mTOR,MAPK/ERK,NF-κB/CREB) 的分析.
检查配方策略,以提高植物化学物质的生物可用性和血脑屏障的透.

主要成果:

植物化学物质 (黄素,白醇,素,EGCG,hesperidin,baicalin) 显示出神经保护和抗抑郁作用.
这些化合物增加BDNF表达,增强突触可塑性,并减少神经炎症.
挑战包括生物可用性差,血脑屏障透性有限,以及可变的治疗反应.

结论:

植物化学物质通过向BDNF途径,为抑郁症治疗提供了一个有希望的途径.
进一步的研究,包括更大的临床试验和机制研究,是必不可少的.
需要改进配方和组合疗法,以将植物化学潜力转化为MDD的有效治疗方法.

关键词:

抗抑郁药物治疗是一种治疗方法.大脑衍生的神经营养因子大型抑郁症主要是抑郁症.植物化学品植物化学品

更多相关视频

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

相关概念视频

Drugs Affecting Neurotransmitter Synthesis

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...

Neurogenesis and Regeneration of Nervous Tissue

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...

Brain Imaging

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...